Information:
Error:
ID
16895
Description
Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00579878
Link
https://clinicaltrials.gov/show/NCT00579878
Keywords
Versions (1)
- 8/13/16 8/13/16 -
Uploaded on
August 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT00579878
Eligibility Rheumatoid Arthritis NCT00579878
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00579878
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
age greater or 19 years and less than or 80 years old
boolean
C0001779 (UMLS CUI [1])
Disease length
Item
duration of disease greater or equal to 6 months
boolean
C0872146 (UMLS CUI [1])
Rheumatoid arthritis: Criteria
Item
diagnosis of ra with criteria
boolean
C0003873 (UMLS CUI [1,1])
C0242801 (UMLS CUI [1,2])
C0242801 (UMLS CUI [1,2])
Pregnancy Test
Item
negative urine pregnancy test
boolean
C0032976 (UMLS CUI [1])
Informed Consent
Item
be capable of understanding and giving written, voluntary informed consent
boolean
C0021430 (UMLS CUI [1])
Number of tender joints
Item
must present with at least six swollen and six tender joints at the screening evaluation
boolean
C0240094 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
Leflunomide
Item
patients treated previously with leflunomide
boolean
C0063041 (UMLS CUI [1])
Methotrexate in combination with study drugs
Item
patients that have been treated with methotrexate in combination with any of the study drugs
boolean
C0025677 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Hypersensitivity: Study Drug
Item
patients with a history of allergy to, or any history of significant clinical or laboratory adverse experience associated with any of the study drugs
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Steroids: Dosage
Item
doses of oral steroids that are either unstable or greater than 10mg/day
boolean
C0038317 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
Grade of disease and rheumatoid lung disease
Item
stage iv disease or other significant disease including chest x-rays that show evidence of rheumatoid lung disease. stage iv disease is defined as x-ray evidence of cartilage/bone destruction with fibrous or bony ankylosis; creatinine greater than 2.0mg/dl, ast or alt greater normal
boolean
C0441800 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C2889132 (UMLS CUI [2])
C0003873 (UMLS CUI [1,2])
C2889132 (UMLS CUI [2])
Comorbidity
Item
any significant liver, renal , hematologic, pulmonary, cardiovascular disease (including uncontrolled hypertension), any active peptic ulcer disease, or visual problems including a recent decrease in acuity, retinal disease, or macular degeneration
boolean
C0009488 (UMLS CUI [1])
Alcohol consumption
Item
patients who are not willing to abstain from alcohol consumption
boolean
C0001948 (UMLS CUI [1])
Gynaecological status
Item
women of childbearing potential who are not practicing a successful method of contraception, or wish to become pregnant
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
Cognitive Function and Informed Consent
Item
patients that are unable to understand the study procedures and/or give written informed consent.
boolean
C0392335 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])